Commentary on 'Metabolic reprogramming-associated genes predict overall survival for rectal cancer'.

The current paper is a commentary on the Metabolic reprogramming-associated genes predict overall survival for rectal cancer (Jian-Qing Lin et al 2020). The authors concluded that 'Patients with high-risk demonstrated significantly poorer survival outcomes than patients with low-risk in the TCGA database. Also, patients with high-risk still showed significantly poorer survival outcomes than patients with low-risk in the GEO database'. But the figure 3 in their published paper, 'Survival analyses for the prognostic metabolic genes in rectal cancer', presented that there was type I error in their study during the hypothesis testing process, obviously.